Product Information
FINASTERIDE 1 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0436 per EA under NDC 57237006130. Its NADAC has been published 523 times since Sep 28, 2016.
FDA first approved this application on Nov 5, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237006130
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FINASTERIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203687FDA Approved
11/5/2013
TE Code
AB
On Market Since
11/5/2013
Pharmacological Classes
Price Statistics
The NADAC for FINASTERIDE 1 MG TABLET has been published 523 times since Sep 28, 2016, and over the history we have for it it has declined 83.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0436 per EA |
|---|---|
| All-time high | $0.2680 (Oct 12, 2016) |
| All-time low | $0.0336 (Nov 20, 2024) |
| 52-week high | $0.0444 |
| 52-week low | $0.0412 |
| Median price | $0.0763 |
| Average price | $0.0888 |
| Largest weekly change | -27.4% (Nov 20, 2024) |
| Weeks tracked | 523 |
| Tracking since | Sep 28, 2016 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 15% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Finasteride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
5-alpha Reductase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FINASTERIDE 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FINASTERIDE 1 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0436 per EA (NDC 57237006130), effective Sep 30, 2026.
How has the price of FINASTERIDE 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for FINASTERIDE 1 MG TABLET has declined 83.7%. It has been tracked across 523 weekly CMS publications since Sep 28, 2016.
What are the highest and lowest recorded NADAC prices for FINASTERIDE 1 MG TABLET?
Since Sep 28, 2016, the NADAC for FINASTERIDE 1 MG TABLET has ranged from a low of $0.0336 (Nov 20, 2024) to a high of $0.2680 (Oct 12, 2016), with a median of $0.0763 per EA.
Are there cheaper alternatives to FINASTERIDE 1 MG TABLET?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FINASTERIDE 1 MG TABLET, is $0.0372 per EA — about 15% below FINASTERIDE 1 MG TABLET.
Who manufactures FINASTERIDE 1 MG TABLET?
FINASTERIDE 1 MG TABLET (NDC 57237006130) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.